Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.
| Website | http://www.exvastat.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical, Drug Development, Preclinical Stage, Innovative Therapeutics, Clinical Trials, Biotechnology, Medicine, Pharmaceutical Research, Drug Repurposing, Therapeutic Development, Life Sciences, Health Technology, Biopharma, Treatment, Medical Research |
Looking for a particular Exvastat employee's phone or email?
Sarah Fritchley is the Chief Development Officer of Exvastat.
1 people are employed at Exvastat.